While focusing on R&D and product capabilities, Giant Biogene has maintained high-quality performance growth. The data shows that from 2019 to 2021, the company's revenue is RMB 957 million, RMB 1.190 billion and RMB 1.552 billion respectively, with a compound annual growth rate of about 27.39%; Profit reached RMB 723 million and RMB 314 million respectively, showing strong profitability.
